Cochlear Limited Stock: price and insider trades · Australia

Headquartered in Sydney, Australia, Cochlear Limited belongs to the Health Care sector and traces its origins to 1981. Filings by its managers are published through ASX. Over the twelve months to 18 October 2026, the company's managers filed 29 filings, from 18 insiders.

Purchases and sales both appear in the filings: 5 purchases (5 insiders, €57k) and 1 sale (1 insider). No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €32k from Michael Grenfell Daniell, disclosed on 24 August 2026, or 0.0006% of market capitalisation. Those buying include 5 senior executives.

For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 29 filings here. Since 2026, the database holds 5 purchases and 1 sale by insiders of the company.

In the case of 4 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (26 August 2026) now reads 52 days. Between a trade and the moment it shows up on ASX, the median delay is 5 days. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.